Cargando…
A Low-Cost Sequencing Platform for Rapid Genotyping in ADPKD and its Impact on Clinical Care
INTRODUCTION: Autosomal-dominant polycystic kidney disease (ADPKD) is the most common genetic cause of kidney failure. Because of the heterogeneity in disease progression in ADPKD, parameters predicting future outcome are important. The disease-causing genetic variant is one of these parameters. MET...
Autores principales: | Lindemann, Christoph Heinrich, Wenzel, Andrea, Erger, Florian, Middelmann, Lea, Borde, Julika, Hahnen, Eric, Krauß, Denise, Oehm, Simon, Arjune, Sita, Todorova, Polina, Burgmaier, Kathrin, Liebau, Max Christoph, Grundmann, Franziska, Beck, Bodo B., Müller, Roman-Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014381/ https://www.ncbi.nlm.nih.gov/pubmed/36938073 http://dx.doi.org/10.1016/j.ekir.2022.12.025 |
Ejemplares similares
-
Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life
por: Todorova, Polina, et al.
Publicado: (2023) -
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
por: Cukoski, Sadrija, et al.
Publicado: (2023) -
Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
por: Arjune, Sita, et al.
Publicado: (2023) -
Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
por: Karner, Larina A., et al.
Publicado: (2022) -
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
por: Fuchs, Alexander, et al.
Publicado: (2022)